Indosin (Indometacin)

Indometacin belongs to the NSAID class and works by inhibiting cyclooxygenase enzymes (COX‑1 and COX‑2). This inhibition reduces the synthesis of prostaglandins, which are mediators of inflammation, pain, and fever. When applied topically, the drug acts locally to lower prostaglandin levels in the skin and underlying tissues, thereby decreasing inflammation and pain.

The appropriate dose of Indosin is determined by the prescribing healthcare professional based on the patient’s condition, severity of symptoms, and treatment response. The prescriber will specify the amount of gel to apply, the frequency of application, and the total duration of therapy.

Safety data for topical indometacin in pregnancy and lactation are limited. Because systemic absorption can occur, it is generally advised to avoid use unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Indosin, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Indosin contains indometacin, which has a potent COX inhibition profile compared with some other topical NSAIDs such as diclofenac or ibuprofen. This can translate into stronger anti‑inflammatory effects for certain conditions, but the safety profile is similar, requiring attention to skin irritation and systemic absorption. Choice of product often depends on physician preference, patient tolerance and specific clinical indication.

Store Indosin at room temperature, preferably below 25 °C. Keep the gel in its original packaging, protect it from moisture, direct sunlight and excessive heat. Do not freeze the product, and ensure the container is tightly closed when not in use.

Clean and dry the affected skin area before use. Apply a thin layer of the gel to the target site and gently rub it in until fully absorbed. Follow the prescriber’s instructions regarding the number of applications per day and avoid covering the area with occlusive dressings unless directed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, systemic gastrointestinal ulceration, liver toxicity, and kidney impairment. Patients should seek immediate medical attention if they experience symptoms like widespread rash, blistering, persistent abdominal pain, jaundice, or sudden changes in urine output.

Indosin should be avoided in individuals with known hypersensitivity to indometacin or any NSAID, those with active peptic ulcer disease, severe renal or hepatic impairment, and patients with uncontrolled asthma triggered by NSAIDs. It is also contraindicated on broken, infected or severely damaged skin.